Wegovy Out-of-Pocket Cost: What You Actually Pay

“Out of pocket” is the figure that matters most, yet it is the hardest to pin down — because it is built from several moving parts rather than one sticker price. Explore the full Peptides & GLP-1 library.

When people ask what Wegovy costs out of pocket, they want the counter total after everything else is applied. That number depends on insurance coverage, the FDA-approved indication on the prescription, savings-card eligibility, pharmacy pricing, and whether a compounded alternative is in play. Here is how those pieces assemble.

What "out of pocket" really includes

Out-of-pocket cost is what you personally pay at the pharmacy after insurance, rebates, coupons, and any manufacturer card are applied. It is distinct from list price, and it is distinct from what your plan pays behind the scenes. Two people with the same prescription can owe very different amounts depending on their coverage.

Starting from the list price

The published starting point is roughly $1,349 per month at U.S. list as of April 2026, per Novo Nordisk. That figure sits before insurance, rebates, savings cards, and pharmacy negotiation, so it is rarely the amount an insured patient actually pays — but it anchors every scenario below.

The three coverage scenarios

Most people fall into one of three buckets, and each produces a very different out-of-pocket result.

Covered indication with a savings card

With commercial insurance that covers the indication and the manufacturer card applied, eligible patients may pay as little as $25 per month, subject to plan terms and card caps. This is the low end of the range and depends entirely on eligibility.

Commercial plan, indication not covered

If the plan does not cover the weight-management indication, cash cost lands closer to list price minus whatever coupon applies. Coverage for chronic weight management is often gated by BMI-based prior authorization or excluded outright, so many patients end up here.

No insurance

Without insurance, cash-pay cost approaches full list price. Medicare, notably, does not cover weight-management drugs for weight alone as of April 2026, though some cardiovascular indications are covered for certain products.

Where savings cards fit

The Novo Nordisk savings card can meaningfully cut monthly cost for eligible commercially-insured patients, but eligibility usually excludes Medicare, Medicaid, TRICARE, and other government insurance. Cards carry monthly and annual caps, and terms change, so confirm current details on the manufacturer site at fill time. Discount platforms like GoodRx and SingleCare publish separate cash prices that vary by pharmacy.

Compounded formulations and separate pricing

Licensed 503A pharmacies produced semaglutide and tirzepatide during the FDA-declared shortages, which were resolved for semaglutide in late 2024 and tirzepatide in early 2025. Compounded products remain available through licensed pathways where justified, are not identical to the brand, and are priced separately. Underneath cost is biology: variants in MC4R and FTO shape appetite. The Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights for context — never predicting drug response — alongside PlexusDx Weight Management Protocols and Tirzepatide Injection.

How prior authorization affects your total

Prior authorization sits quietly behind many out-of-pocket surprises. Even a plan that lists Wegovy may require documentation — often BMI-based — before it will cover the weight-management indication, and until that clears, a patient can face cash pricing. Some plans exclude the indication regardless, which pushes the total toward list price minus any coupon. Because these rules and the published prices behind them change, the reliable move is to confirm both your plan’s authorization requirements and the current pharmacy price at the time of fill. Starting the paperwork early through the prescriber’s office is often what turns a high quoted number into a manageable one.

Two people with seemingly identical plans can still land in different buckets because of formulary tiers, deductible status, and whether the deductible has been met for the year. That is why a general price range only takes you so far. The dependable answer comes from your own plan documents and a benefits check, ideally run before the first fill so the out-of-pocket figure is a known quantity rather than a counter-side shock.

Frequently Asked Questions

What will Wegovy actually cost me each month?

It ranges from as little as $25 with covered commercial insurance and a savings card, up toward the roughly $1,349 list price without coverage. Your figure depends on the indication on the prescription, your plan’s formulary and prior-authorization rules, and any coupon or card you qualify for.

Does Medicare cover Wegovy for weight loss?

As of April 2026, Medicare does not cover weight-management drugs for weight alone. Some cardiovascular indications are covered for certain products, so coverage hinges on why the drug is prescribed. Confirm the specifics directly with your plan, since rules and covered indications continue to evolve.

How much can a savings card save?

For eligible commercially-insured patients, the manufacturer card can bring monthly cost down substantially, sometimes to around $25, subject to caps. It generally excludes government-insurance patients. Verify eligibility and current terms on the manufacturer site at the time you fill the prescription.

Are compounded versions cheaper?

Compounded semaglutide and tirzepatide are priced separately by licensed 503A pharmacies and can differ from brand cost, but they are legally distinct products, not generics. PlexusDx publishes per-protocol pricing on its product pages. Discuss whether a compounded option is clinically appropriate with a qualified provider.

Continue learning inside the PlexusDx Education Hub. Browse more Peptides & GLP-1 education.